Longview Asset Management (New Mexico)’s AbbVie ABBV Stock Holding History

Longview Asset Management (New Mexico)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$352K	Buy	1,541 +475	+45%	+$108K	0.25%	33
2025 Q3	$247K	Sell	1,066 -39	-4%	-$7.94K	0.17%	38
2025 Q2	$205K	Buy	1,105 +29	+3%	+$5.39K	0.16%	51
2025 Q1	$225K	Buy	+1,076	New	+$209K	0.19%	51

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Longview Asset Management (New Mexico)'s ABBV Position: Q4 2025 in Review

Longview Asset Management (New Mexico) increased its AbbVie (ABBV) stake by 45% in Q4 2025, buying an estimated $108K and bringing the position to 1,541 shares worth $352K. The position accounts for 0.25% of the portfolio, ranked #33.

Longview Asset Management (New Mexico) first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. 4,150 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Longview Asset Management (New Mexico) held 1,541 shares of AbbVie worth $352K as of Q4 2025.
Longview Asset Management (New Mexico) bought 475 AbbVie shares in Q4 2025, an estimated $108K.
AbbVie made up 0.25% of Longview Asset Management (New Mexico)'s portfolio in Q4 2025, its #33 holding.
Longview Asset Management (New Mexico) first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
4,150 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Longview Asset Management (New Mexico)'s 13F filing for Q4 2025, filed 9 Feb 2026.